Literature DB >> 15465088

Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders.

Toshiyuki Fukazawa1, Seiji Kikuchi, Masaaki Niino, Ichiro Yabe, Ryuji Miyagishi, Hikoaki Fukaura, Takeshi Hamada, Kunio Tashiro, Hidenao Sasaki.   

Abstract

Understanding the spectrum of idiopathic inflammatory demyelinating disorders (IIDD) is a fundamental issue for the diagnosis and treatment of these disorders as well as for the approach to their pathogenesis. The spectrum of IIDD is usually classified according to clinical course and lesion distribution. We compared the demographic features, clinical characteristics, laboratory findings, and genetic backgrounds between 193 Japanese patients with and without clinically or radiographically fulminant attacks who all satisfied the diagnostic criteria for multiple sclerosis (MS). "Fulminant attacks" in the current study represent attack-related clinically or radiologically severe relapses but do not necessarily mean severe disability. Patients with fulminant attacks were clinically and immunogenetically distinct from those free of such attacks, and the previously described characteristics of the opticospinal form of MS (OSMS) or neuromyelitis optica (NMO) were mostly shared by patients with fulminant attacks. HLA profiles were similar among patients with fulminant attacks irrespective of the lesion distributions. The GG homozygous and G alleles of the CTLA4 gene A/G coding SNP at position 49 in exon 1 were significantly more common in patients with fulminant attacks than in those without. Attack-related severity may be an important factor if validated by prospective studies defining criteria and establishing relationships to disease course and treatment regimens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465088     DOI: 10.1016/j.jns.2004.07.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  [Revision of McDonald's new diagnostic criteria for multiple sclerosis].

Authors:  H Wiendl; B C Kieseier; R Gold; R Hohlfeld; M Bendszus; H-P Hartung
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

2.  Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features.

Authors:  Ichiro Nakashima; Toshiyuki Fukazawa; Kohei Ota; Chiyoko Nohara; Yoko Warabi; Takashi Ohashi; Isabelle Miyazawa; Kazuo Fujihara; Yasuto Itoyama
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

3.  White matter disease: Early treatment of inflammatory demyelinating disease.

Authors:  Naraporn Prayoonwiwat; Sasitorn Siritho
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

4.  Fulminant multiple sclerosis (MS).

Authors:  Mohammad Rohani; Shadi Ghourchian
Journal:  Neurol Sci       Date:  2011-08-24       Impact factor: 3.307

5.  Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.

Authors:  Zhengqi Lu; Bingjun Zhang; Wei Qiu; Zhuang Kang; Liping Shen; Youming Long; Junqi Huang; Xueqiang Hu
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

Review 6.  Idiopathic inflammatory-demyelinating diseases of the central nervous system.

Authors:  A Rovira Cañellas; A Rovira Gols; J Río Izquierdo; M Tintoré Subirana; X Montalban Gairin
Journal:  Neuroradiology       Date:  2007-02-28       Impact factor: 2.995

Review 7.  The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis.

Authors:  Maria Sofia Basile; Placido Bramanti; Emanuela Mazzon
Journal:  Genes (Basel)       Date:  2022-07-24       Impact factor: 4.141

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.